Home > Investor Relation > Biotech Investment   
 
Company
Investment Date
Research projects
A & Pep (*)
Mar. 2001
 1) New Intermediate development for peptide
    synthesis
2) New Drug Delivery system development
Biobud
May. 2000
 Recombinant gene cloning and purification
(*) A & Pep: Spin-off company from Hyundai Pharm.
Remarks : HYUNDAI have worldwide marketing right to all products which will be coming from HYUNDAI’s investments.


1. Investment to company itself to take some shares
- automatically get marketing right in all Asian countries (including Japan) for all products which were developed by biotech company.
2. Investment to project itself (not company)
- automatically get marketing right in all Asian countries (including Japan).
3. Buyout of candidate compound
- New chemical entity which Biotech companies developing.
- Hyundai will buy it for further development in worldwide basis.
In 1 & 2 : Hyundai eagerly joining clinical trials with Asian people.
 
main_footer